myelofibrosis

Showing NaN - NaN of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelofibrosis Trial in Worldwide (GB2064)

Recruiting
  • Myelofibrosis
  • Houston, Texas
  • +11 more
Nov 23, 2022

Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +165 more
Aug 19, 2022

Myelofibrosis Trial in Worldwide (TL-895)

Recruiting
  • Myelofibrosis
  • Aurora, Colorado
  • +65 more
Jun 2, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Myelofibrosis Trial in Italy (A: Fludarabine + Busulphan, B: Fludarabine + Thiotepa)

Completed
  • Myelofibrosis
  • A: Fludarabine + Busulphan
  • B: Fludarabine + Thiotepa
  • Alessandria, Italy
  • +20 more
Aug 19, 2021

Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

Completed
  • Polycythemia Vera
  • +2 more
  • JAK2V617F mutation
  • Olomouc, Czechia
  • +29 more
Dec 5, 2019

Myelofibrosis Trial in Worldwide (Ruxolitinib, Best Available Therapy (BAT))

Completed
  • Myelofibrosis
  • Innsbruck, Austria
  • +60 more
Jul 11, 2019

Myelofibrosis Trial in Worldwide (INC424)

Completed
  • Myelofibrosis
  • Alger, Algeria
  • +272 more
Apr 25, 2019

Acute Myeloblastic Leukemia, Lymphoblastic Leukemia, Myelodysplasia Trial in Italy (Alentuzumab, Globulina antilinfocitaria)

Completed
  • Acute Myeloblastic Leukemia
  • +5 more
  • Alessandria, Italy
  • +21 more
Mar 20, 2014

Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia Trial in Worldwide (Deferasirox)

Completed
  • Thalassemia
  • +3 more
  • Little Rock, Arkansas
  • +140 more
Jun 3, 2011